Compare LASE & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LASE | VTGN |
|---|---|---|
| Founded | 2019 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.0M | 21.8M |
| IPO Year | 2021 | 2014 |
| Metric | LASE | VTGN |
|---|---|---|
| Price | $1.06 | $0.62 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | ★ 2.9M | 880.5K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.54 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $721,185.00 | N/A |
| Revenue This Year | N/A | $93.93 |
| Revenue Next Year | N/A | $243.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.38 | $0.43 |
| 52 Week High | $6.77 | $5.14 |
| Indicator | LASE | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 44.26 |
| Support Level | $0.38 | $0.50 |
| Resistance Level | $1.19 | $0.77 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 70.65 | 82.40 |
Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.